drugset / Trial / NCT00539669
TAX + Carboplatin or Cisplatin 1st Line Post-Surgery Ovarian
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Evaluate response rate of Docetaxel in combination with Carboplatin or Cisplatin as first line chemotherapy in epithelial ovarian cancer. Assess the progression free survival, tolerance, duration of response and survival in the same patient population.
Timeline
- Start
- 2003-03
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | — | — |